GCG and Hyperglycemia: Therefore, this study aimed at exploring whether glucagon and GLP-1 secretion and related PC2 (proconvertase 2) or PC1/3 expression could be modulated by metabolic alterations typically occurring in type 2 diabetes, such as hyperglycemia, hyperlipidemia, hyperglucagonemia, and subclinical inflammation.